The recommended dose for VIRAMUNE is one 200-mg tablet daily for the first 14 days, followed by one 200-mg tablet big, in combination with antiretroviral agents. This lead-in period should be used because it has been found to lessen the frequency of rash.
Detailed dosing instructions are given in the chart below.
Patients who interrupt VIRAMUNE dosing for more than 7 days should restart the recommended dosing, using one 200 mg tablet daily (4 mg/kg/day in pediatric patients) for the first 14 days (lead-in) followed by one 200 mg tablet twice daily (4 or 7 mg/kg twice daily, according to age, for pediatric patients).
Please consult Full Prescribing Information, including boxed WARNING, Medication Guide, and Important Safety Information for VIRAMUNE.
